Literature DB >> 10910173

Update: the twenty subtypes of HLA-B27.

M A Khan.   

Abstract

HLA-B27 is a serologic specificity that encompasses 20 different alleles-HLA-B*2701 to B*2720. These alleles are also called subtypes of HLA-B27, and they have evolved from the B*2705 subtype, mostly from changes in exons 2 and 3 (which encode the alpha 1 and alpha 2 domains of the peptide binding groove, respectively). Occurrence of ankylosing spondylitis (AS) or related spondyloarthropathy (SpA) has thus far been documented in subjects possessing any one of the first 10 subtypes. However, B*2706 in Southeast Asian and B*2709 in the Italian island population of Sardinia may have a relatively much weaker association with AS. The 10 most recent subtypes have not yet been studied for disease association. There may exist a hierarchical ranking, resulting, in part, from differences in other co-inherited genetic factors, or due to environmental factors; eg, B*2705 is clearly disease-associated throughout the world, but not among the West Africans of Senegal and Gambia. It is important to investigate whether certain subtypes show any preferential association with some of the clinical features or forms of AS and related SpA among the various ethnic/racial populations and geographic regions of the world. This may help to identify the polymorphic positions of HLA-B27 that may have a disease-predisposing role.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910173     DOI: 10.1097/00002281-200007000-00001

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  10 in total

1.  Remarkable polymorphism of HLA-B27: an ongoing saga.

Authors:  Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

2.  Pathophysiology of spondyloarthritis.

Authors:  Monika Ronneberger; Georg Schett
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

Review 3.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

Review 5.  Juvenile onset spondyloarthropathies: therapeutic aspects.

Authors:  R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 6.  Mechanisms of bone resorption and new bone formation in spondyloarthropathies.

Authors:  Willis Huang; Edward M Schwarz
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 7.  Ankylosing spondylitis in a Malawian.

Authors:  N C Mkandawire
Journal:  Malawi Med J       Date:  2003       Impact factor: 0.875

8.  Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation.

Authors:  Terry C C Lim Kam Sian; Saranjah Indumathy; Hanim Halim; Anja Greule; Max J Cryle; Paul Bowness; Jamie Rossjohn; Stephanie Gras; Anthony W Purcell; Ralf B Schittenhelm
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

9.  Prevalence and clinical manifestations of ankylosing spondylitis in young Greek males.

Authors:  D G Kassimos; J Vassilakos; G Magiorkinis; A Garyfallos
Journal:  Clin Rheumatol       Date:  2014-03-20       Impact factor: 2.980

10.  Predominant frequency of HLA-B*27 in patients with ankylosing spondylitis in southeastern China.

Authors:  JiaoJiao Lu; Jing Yang; WenXu Dong; BaoJia Tang; LuoYuan Cao; YingHua Lin; BaoYing Huang; XianGuo Fu
Journal:  Immun Inflamm Dis       Date:  2021-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.